These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27101282)

  • 21. [Iron and inflammation in renal diseases].
    Łukaszyk E; Małyszko J
    Przegl Lek; 2014; 71(2):95-7. PubMed ID: 25016784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How to Supplement Iron in Patients with Renal Anemia.
    Tanaka S; Tanaka T
    Nephron; 2015; 131(2):138-44. PubMed ID: 26381391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of Iron-Deficiency Anemia in Chronic Kidney Disease.
    Bahrainwala J; Berns JS
    Semin Nephrol; 2016 Mar; 36(2):94-8. PubMed ID: 27236129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease: therapeutic considerations.
    Molony DA; Stephens BW
    Adv Chronic Kidney Dis; 2011 Mar; 18(2):120-31. PubMed ID: 21406297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron deficiency across chronic kidney disease stages: Is there a reverse gender pattern?
    Aoun M; Karam R; Sleilaty G; Antoun L; Ammar W
    PLoS One; 2018; 13(1):e0191541. PubMed ID: 29357391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepcidin in chronic kidney disease: not an anaemia management tool, but promising as a cardiovascular biomarker.
    van der Weerd NC; Grooteman MP; Nubé MJ; ter Wee PM; Swinkels DW; Gaillard CA
    Neth J Med; 2015 Mar; 73(3):108-18. PubMed ID: 25852110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between hepcidin, haemoglobin level and iron status in stage 4 chronic kidney disease patients with anaemia.
    Mogadam RA; Nemati A; Amani F; Ghorbanihaghjo A; Argani H; Bashardoust B
    J Pak Med Assoc; 2015 Apr; 65(4):354-7. PubMed ID: 25976565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anemia in chronic kidney disease patients: treatment recommendations and emerging therapies.
    Del Vecchio L; Locatelli F
    Expert Rev Hematol; 2014 Aug; 7(4):495-506. PubMed ID: 25025373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of intravenous iron supplementation in chronic kidney disease: Interests, limits, and recommendations for a better practice].
    Rottembourg J; Rostoker G
    Nephrol Ther; 2015 Dec; 11(7):531-42. PubMed ID: 26498106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ferric Citrate in Patients With Chronic Kidney Disease.
    Block GA
    Semin Nephrol; 2016 Mar; 36(2):130-5. PubMed ID: 27236135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation.
    Icardi A; Paoletti E; De Nicola L; Mazzaferro S; Russo R; Cozzolino M
    Nephrol Dial Transplant; 2013 Jul; 28(7):1672-9. PubMed ID: 23468534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron therapy in chronic kidney disease: current controversies.
    Kovesdy CP; Kalantar-Zadeh K
    J Ren Care; 2009 Dec; 35 Suppl 2():14-24. PubMed ID: 19891681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron Status and Inflammation in Early Stages of Chronic Kidney Disease.
    Łukaszyk E; Łukaszyk M; Koc-Żórawska E; Tobolczyk J; Bodzenta-Łukaszyk A; Małyszko J
    Kidney Blood Press Res; 2015; 40(4):366-73. PubMed ID: 26160488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia.
    Garrido P; Ribeiro S; Fernandes J; Vala H; Rocha-Pereira P; Bronze-da-Rocha E; Belo L; Costa E; Santos-Silva A; Reis F
    Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26712750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iron status and benefit of the use of parenteral iron therapy in pre-dialysis Chronic Kidney disease patients.
    Arogundade FA; Soyinka FO; Sanusi AA; Ojo OE; Akinsola A
    Niger Postgrad Med J; 2013 Dec; 20(4):299-304. PubMed ID: 24633272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study.
    Charytan C; Bernardo MV; Koch TA; Butcher A; Morris D; Bregman DB
    Nephrol Dial Transplant; 2013 Apr; 28(4):953-64. PubMed ID: 23222534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Iron supplementation is recommended in renal anemia].
    Stefansson B
    Lakartidningen; 2015 Mar; 112():. PubMed ID: 25756713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology of anemia in chronic kidney diseases: A review.
    Zadrazil J; Horak P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):197-202. PubMed ID: 24401900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepcidin.
    Ganz T
    Rinsho Ketsueki; 2016; 57(10):1913-1917. PubMed ID: 27725588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.